Nile Therapeutics, Inc (NLTX) Stock News, Earnings & History

(NASDAQ:NLTX) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 0.22
52wk low: 0.02
EPS: -0.10
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 3.57M
Avg Vol (3m): 40,850

Latest Headlines

    No articles on Nile Therapeutics, Inc in the past week.

More Articles About NLTX →

Company On Twitter

Company Profile

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops products for the treatment of cardiovascular disease and other areas of unmet medical needs.


Investor Relations | Press Releases

Insider Trading Cheat Sheet

No insider trading data available for Nile Therapeutics, Inc.

Yahoo, HV, Market Watch, The Wall St. Journal